NCT06809790

Brief Summary

Patients between the ages of 20-65 years who present to the Physical Medicine and Rehabilitation outpatient clinics of our hospital with complaints of back and neck pain and are diagnosed with myofascial pain syndrome will be referred to the physicians responsible for the study to be included in the study. Exclusion criteria will be reviewed, and patients with chronic pain for more than 3 months and an active trigger point in the unilateral upper trapezius muscle will be included in the study. Patients will be randomly divided into two groups; the first group will receive only exercise therapy (including cervical range of motion and trapezius stretching), and the second group will receive exercise and dry needling therapy (1 time per week, 3 sessions in total). Demographic data (age, gender, body mass index, occupation) of all patients included in the study will be recorded. The relationship between pain and loss of function according to the Visual Analog Scale (VAS), Short Form 36 (SF-36), and Neck Disability Index (NDI) scales will be recorded. Bilateral upper trapezius, sternocleidomastoideus, and total cervical extensor muscle thickness (upper trapezius, splenius capitis, semispinalis capitis, semispinalis cervicis, and multifidus) and longus colli muscle thickness measurements will be made with the ultrasonography device in our clinic. The first group will receive only exercise therapy after the measurements. Patients in the second group will receive a total of 3 sessions of dry needling treatment to the trapezius muscle for active trigger points at 0, 1, and 2 weeks in addition to exercise therapy. After the initial examination, control VAS, SF-36, NDI, and control ultrasonographic measurements will be performed in all patients at the 3rd week and 6th week. Using data analysis methods, the effect of dry needling treatment for active trigger points in the trapezius muscle on pain and functionality as well as the thickness of the cervical muscles will be investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

February 9, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2025

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2025

Completed
Last Updated

August 19, 2025

Status Verified

August 1, 2025

Enrollment Period

6 months

First QC Date

January 26, 2025

Last Update Submit

August 18, 2025

Conditions

Keywords

myofascial pain syndrometrigger pointdry needlingupper trapezius muscleTherapeutic Exercise

Outcome Measures

Primary Outcomes (1)

  • Ultrasonographic evaluation for muscle thickness assessment

    Bilateral upper trapezius, sternocleidomastoid, total cervical extensor muscle thickness (upper trapezius, splenius capitis, semispinalis capitis, semispinalis cervicis, and multifidus), and longus colli muscle thickness measurements will be made with the ultrasonography device.

    It will be evaluated in the baseline, third, and sixth weeks.

Secondary Outcomes (3)

  • Pain will be assessed with Visual Analog Scale.

    It will be evaluated in the baseline, third, and sixth weeks.

  • Functional status will be assessed with the Neck Disability Index.

    It will be evaluated in the baseline, third, and sixth weeks.

  • General health status will be assessed with Short Form 36.

    It will be evaluated in the baseline, third, and sixth weeks.

Study Arms (2)

Group 1: Therapeutic Exercise

ACTIVE COMPARATOR
Behavioral: Therapeutic Exercise Program

Group 2: Therapeutic Exercise and Dry Needling

ACTIVE COMPARATOR
Behavioral: Therapeutic Exercise ProgramProcedure: Dry Needling

Interventions

Participants in this group will receive a therapeutic exercise program (including cervical range of motion and trapezius stretching) during the study period.

Group 1: Therapeutic ExerciseGroup 2: Therapeutic Exercise and Dry Needling
Dry NeedlingPROCEDURE

Participants in this group will receive dry needling treatment for active trigger points in addition to the therapeutic exercise program. Dry needling treatment will be applied in a total of 3 sessions at 0, 1, and 2. weeks, one week apart.

Group 2: Therapeutic Exercise and Dry Needling

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 20-65 years with neck pain for more than 12 weeks
  • Active trigger point in the unilateral upper trapezius muscle on physical examination
  • Who agreed not to receive anti-inflammatory and myorelaxant treatment during the study period

You may not qualify if:

  • Patients diagnosed with rheumatologic diseases
  • Patients with radiculopathy
  • Patients with a history of previous surgery in the shoulder, back, and neck region
  • Patients with polyneuropathy
  • Patients with severe cervical spondylosis
  • Patients with cerebrovascular events
  • Patients with malignancies
  • Those with cognitive impairment
  • Those with bleeding disorders
  • Patients diagnosed with fibromyalgia
  • Patients with thyroidectomy
  • Anti-inflammatory-analgesic or myorelaxant treatment within the last 1 month
  • Patients with a history of injection into the upper trapezius muscle or cervical region within the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Training and Research Hospital

Istanbul, Fatih, 34093, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Myofascial Pain Syndromes

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • Muhammed Oğuz

    Istanbul Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly divided into two groups; the first group will receive only exercise therapy, and the second group will receive exercise therapy as well as dry needling treatment.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

January 26, 2025

First Posted

February 5, 2025

Study Start

February 9, 2025

Primary Completion

July 25, 2025

Study Completion

August 15, 2025

Last Updated

August 19, 2025

Record last verified: 2025-08

Locations